Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Slayback Rivals Xiromed On Taytulla – But With First CGT Designation
Eligible For 180 Days Of CGT Exclusivity
Dec 22 2020
•
By
Dean Rudge
The FDA finalized CGT guidance earlier this year • Source: Shutterstock
More from Products
More from Generics Bulletin